相关实验视频

Updated: Jun 9, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

与代谢功能障碍相关的脂肪性肝病相关的阿波利波蛋白C-III:一个大型的多中心研究

Matina Kouvari¹, Laura Valenzuela-Vallejo¹, Valentina Guatibonza-Garcia¹

¹Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Clinical nutrition (Edinburgh, Scotland)

|October 23, 2024

概括

在与代谢功能障碍相关的晚期脂肪性肝病 (MASLD) 中,阿波利波蛋白C-III (ApoC-III) 的水平可能会降低. 较低的ApoC-III与正常的甘油三与严重的MASLD风险降低有关,这表明它具有保护作用.

科学领域:

肝病学肝病学是一种肝病学.
代谢疾病代谢疾病
生物化学生物化学

背景情况:

在文献中存在关于在代谢功能障碍相关的脂肪性肝病 (MASLD) 中抑制阿波利波蛋白C-III (ApoC-III) 的不一致性.
MASLD涵盖了一系列由代谢功能障碍驱动的肝脏疾病.

研究的目的:

调查整个代谢功能障碍相关的脂肪性肝病 (MASLD) 的全谱的阿波利波蛋白C-III (ApoC-III) 水平.
探索ApoC-III,甘油三和晚期MASLD风险之间的关联.

主要方法:

多中心研究包括来自胃肠病学-肝病学和腹代谢手术诊所的患者.
在干预 (低血压手术或生活方式修改) 之前和之后进行肝脏活检.

主要成果:

在高危代谢功能障碍相关的脂肪肝炎 (MASH) 与晚期纤维化 (F≥2) 中观察到一种降低ApoC-III的趋势.
ApoC-III与风险MASH相反相关;ApoC-III水平与甘油三相互作用,预测疾病风险.
与高ApoC-III相结合的正常甘油三,与低ApoC-III和高甘油三血症相比,显著降低了风险MASH的几率.

结论:

在与代谢功能障碍相关的脂肪性肝病 (MASLD) 的晚期阶段,阿波利波蛋白C-III (ApoC-III) 的水平似乎会下降.
先进的器官损伤可能会解释严重的MASLD中ApoC-III水平的降低.
需要进一步的门德尔随机化研究来验证这些发现并探索因果关系.

关键词:

这是一种Apolipoprotein蛋白质.脂肪肝疾病是一种脂肪肝疾病.脂质脂质脂质是一种肝脏纤维化肝脏纤维化这是NAFLD.

更多相关视频

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...